Ticker
SPRYCompany Name
ARS PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Earning Before Interest & Taxes (EBIT) | EBIT Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -47.73M | -42.49% | $ 112.34M |
3/31/2025 | $ -15.36M | -15.82% | $ 97.12M |
12/31/2024 | $ 8.29M | 9.29% | $ 89.15M |
9/30/2024 | $ -49.1M | -1912.15% | $ 2.57M |
6/30/2024 | $ -44.84M | -8968.4% | $ 500K |
3/31/2024 | $ -49.7M | -496960% | $ 10K |
12/31/2023 | $ -54.37M | -181216.67% | $ 30K |
9/30/2023 | $ -19.95M | -1482.54% | $ 1.35M |
6/30/2023 | $ -22.95M | -1705.27% | $ 1.35M |
3/31/2023 | $ -25.01M | -1872.16% | $ 1.34M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBIT / Revenues
(=) EBIT %
EBIT % for ARS PHARMACEUTICALS INC is calculated as follows: EBIT [ $ -23.97M ] / Revenues [ $ 0 ]
(=) EBIT % [ 0% ]
Minimum
Mar 31, 2024
Maximum
Dec 31, 2024
Average
Median
filtered constituents | 3.26K |
---|---|
min | -73.16% |
max | 83.08% |
average | 9.54% |
median | 9.01% |
std | 23.96% |